Filing Details

Accession Number:
0001179110-15-006726
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-28 16:32:02
Reporting Period:
2015-04-24
Filing Date:
2015-04-28
Accepted Time:
2015-04-28 16:32:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
203077 St Jude Medical Inc STJ Electromedical & Electrotherapeutic Apparatus (3845) 411276891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1533175 Joel Becker One St. Jude Medical Drive
St. Paul MN 55117
President, Americas No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-24 2,666 $41.65 2,809 No 4 M Direct
Common Stock Disposition 2015-04-24 2,666 $73.87 143 No 4 S Direct
Common Stock Acquisiton 2015-04-24 2,998 $52.98 3,141 No 4 M Direct
Common Stock Disposition 2015-04-24 2,998 $73.87 143 No 4 S Direct
Common Stock Acquisiton 2015-04-24 12,206 $59.41 12,349 No 4 M Direct
Common Stock Disposition 2015-04-24 12,206 $73.87 143 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2015-04-24 2,666 $0.00 2,666 $41.65
Common Stock Stock Options (Right to Buy) Disposition 2015-04-24 2,998 $0.00 2,998 $52.98
Common Stock Stock Options (Right to Buy) Disposition 2015-04-24 12,206 $0.00 48,824 $59.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-12-14 2018-12-14 No 4 M Direct
0 2012-04-06 2019-04-06 No 4 M Direct
36,618 2014-12-17 2021-12-10 No 4 M Direct
Footnotes
  1. The price in Column 4 is the greater of the two prices received . The prices actually received were $73.17and $74.17. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  2. Fully vested at the time of filing.
  3. The option shares vest 25% on each of the first four anniversary dates of the date of the grant beginning on the date shown.
  4. The option shares will vest 25% on December 17th annually beginning the date shown.